Yunchao Chang

Title: Yunchao Chang: Innovator in Pharmaceutical Research

Introduction

Yunchao Chang is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that modulate protein activity. With a total of 3 patents, his work is paving the way for advancements in treating various clinical conditions.

Latest Patents

Yunchao Chang's latest patents include the development of substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs. These compounds are recognized for their potential as modulators of cereblon protein activity. The patents detail methods of making these compounds, pharmaceutical compositions that include them, and their application in treating disorders associated with uncontrolled cellular proliferation, such as cancer. The disclosed compounds can selectively modulate the degradation of GSPT1 protein, acting as GSPT1 degraders, which is crucial for addressing cereblon protein dysfunction.

Career Highlights

Yunchao Chang is affiliated with St. Jude Children's Research Hospital, where he continues to engage in groundbreaking research. His work is instrumental in the development of innovative therapeutic strategies aimed at improving patient outcomes in oncology and other related fields.

Collaborations

Some of his notable coworkers include Fatemeh Keramatnia and Kevin McGowan, who contribute to the collaborative research environment at St. Jude Children's Research Hospital.

Conclusion

Yunchao Chang's innovative work in pharmaceutical research exemplifies the impact of dedicated inventors in advancing medical science. His contributions are vital for the development of new treatments that can significantly improve the lives of patients facing serious health challenges.